Clinical Trials for Hereditary Hemorrhagic Telangiectasia

Comprehensive HHT Outcomes Registry of the United States (CHORUS)

NCT ID: NCT06259292

The Comprehensive HHT Outcomes Registry of the United States (CHORUS) is a study aimed at understanding Hereditary Hemorrhagic Telangiectasia (HHT), a condition that causes abnormal blood vessel fo...

Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia

NCT ID: NCT05641142

This clinical trial is looking to understand how well patients with Hereditary Hemorrhagic Telangiectasia (HHT), also known as Rendu-Osler Disease, tolerate treatment with blood-thinning medication...

Quality of Life in Patients With Hemorrhagic Telangiectasia

NCT ID: NCT06261333

Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic Telangiectasia

NCT ID: NCT04469517

This clinical trial is studying how certain factors related to low oxygen levels (called hypoxic induced factors) might affect patients with hereditary hemorrhagic telangiectasia (HHT). HHT is a ge...

Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia

NCT ID: NCT03850730

This clinical trial is studying a medication called Pazopanib to see if it can help reduce frequent and severe nosebleeds (epistaxis) in people with a genetic condition known as hereditary hemorrha...